Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92457918 | 9245791 | 8 | F | 2010 | 20160804 | 20130422 | 20160809 | EXP | US-009507513-1112USA02606 | MERCK | 0.00 | M | Y | 0.00000 | 20160809 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92457918 | 9245791 | 1 | PS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | 380 | MG | 20788 | 1 | MG | FILM-COATED TABLET | QD | ||||
| 92457918 | 9245791 | 2 | SS | PROPECIA | FINASTERIDE | 1 | 380 | MG | 20788 | FILM-COATED TABLET | |||||||||
| 92457918 | 9245791 | 3 | C | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92457918 | 9245791 | 1 | Alopecia |
| 92457918 | 9245791 | 2 | Androgenetic alopecia |
| 92457918 | 9245791 | 3 | Autism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92457918 | 9245791 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92457918 | 9245791 | Amnesia | |
| 92457918 | 9245791 | Anxiety | |
| 92457918 | 9245791 | Attention deficit/hyperactivity disorder | |
| 92457918 | 9245791 | Bladder outlet obstruction | |
| 92457918 | 9245791 | Cognitive disorder | |
| 92457918 | 9245791 | Depression | |
| 92457918 | 9245791 | Diarrhoea | |
| 92457918 | 9245791 | Drug ineffective | |
| 92457918 | 9245791 | Erectile dysfunction | |
| 92457918 | 9245791 | Headache | |
| 92457918 | 9245791 | Hypertonic bladder | |
| 92457918 | 9245791 | Lower urinary tract symptoms | |
| 92457918 | 9245791 | Paraesthesia | |
| 92457918 | 9245791 | Pelvic floor muscle weakness | |
| 92457918 | 9245791 | Penile size reduced | |
| 92457918 | 9245791 | Prostatitis | |
| 92457918 | 9245791 | Prostatomegaly | |
| 92457918 | 9245791 | Sexual dysfunction | |
| 92457918 | 9245791 | Terminal dribbling | |
| 92457918 | 9245791 | Urinary tract obstruction | |
| 92457918 | 9245791 | Urine flow decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92457918 | 9245791 | 1 | 20100713 | 20110727 | 0 | |
| 92457918 | 9245791 | 3 | 2008 | 0 |